Djibouti vs Iran: Cause of death, by non-communicable diseases, ages 15-59, male
Djibouti
40.6%
in 2021
Iran
40.8%
in 2021
Djibouti rank
132nd
Iran rank
130th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Djibouti
- Iran
How they compare
Iran currently reports 40.8% against 40.6% in Djibouti, a difference of 0.2%.
Across all 6 years both countries report, Iran has been ahead every year.
Djibouti ranks 132nd and Iran ranks 130th of 185 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 27.7% | 55.1% | 27.4% | Iran |
| 2010s | 35.5% | 59.1% | 23.6% | Iran |
| 2020s | 41.5% | 44.6% | 3.1% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Djibouti or Iran?
- Iran, at 40.8% against 40.6% in Djibouti as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Djibouti and Iran?
- 0.2%, with Iran ahead.
- How many years of comparable data are there for Djibouti and Iran?
- 6 years are reported by both, from 2000 to 2021.
- How do Djibouti and Iran rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Djibouti ranks 132nd and Iran ranks 130th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.